50% off Premium Yearly

NYSE:STZ
This summary was created by AI, based on 2 opinions in the last 12 months.
Constellation Brands Inc, with the ticker STZ-N, is set to report earnings soon, and there are mixed sentiments among experts regarding its prospects. One expert expresses optimism in the company's new CEO, anticipating a potential turnaround in beer and cocktail sales. Conversely, another review highlights challenges faced by the alcohol sector, notably mentioning a decline in sales attributed to external factors such as ICE raids in key shopping areas. This expert points out a significant drop of 36% in stock price this year, deeming it to be trading at a low price-to-earnings ratio of 12x. However, they argue that this valuation may be justified due to ongoing weakening of sales and the competitive threat from emerging GLP-1 drugs that may impact consumer spending habits on alcohol products. The contrasting views illustrate the uncertainty surrounding the stock's future performance, especially in the context of broader industry trends.
Last week, it reported stellar numbers but shares still fell, a victim to persistent misconceptions. Their Modelo is the #1 beer in the US and is gaining market share. Pacifico sales are up 21%. STZ operating margins were up 260 basis points. They beat Q1 EPS. Shares should be selling at $300. The problem is STZ also sells hard liquor, which Wall Street has given up on as well as doubts that beer's popularity is waning. Has huge free cash flow, are buying back shares, and is expanding facilities. Other threats are the weight-loss drugs and the popularity of cannabis. He won't abandon this stock though.
He's long owned this, but the stock has hit several road blocks including a bad investment in cannabis-maker Canopy Growth and the company founders selling huge amounts of shares. he's stuck with it, because he believes in their Mexican beers like Modelo. They just reported solid numbers, like an earnings beat, and a sunny forecast about beer sales even wine/spirits isn't doing as well. Is a long way from last year's highs, but is undervalued.
Stock has been sinking for months and faces concerns of the eight-loss drugs impacted their beer sales.